You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
內地適時將開展新批次藥品及高值醫用耗材集採
國家醫療保障局副局長施子海在發布會上表示,長期以來,內地藥品和高值醫用耗材價格存在虛高現象,特別是一些「進口老藥」,儘管已經過專利期,但仍以較高的價格內地銷售,高值醫用耗材價格更是遠高於國際水平。針對該狀況,國家醫保局將會同有關部門積極推進藥品、高值醫用耗材集採,通過降低中選企業的生產和營銷成本,實現中選產品降價。 下一步,將持續推進醫藥集中帶量採購的擴面提質,堅持國家和地方上下聯動、一體推進。在國家層面上,今年已開展第八批藥品集採,還將開展第四批高值醫用耗材的集採,主要是針對眼科的人工晶體和骨科的運動醫學類耗材,適時還將開展新批次的藥品集採。在地方層面上,將重點對國家組織集採以外的化學藥、中成藥、干擾素以及神經外科耗材、體外診斷試劑等開展省際聯盟採購。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account